| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
8,161 |
7,784 |
$1.49M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
10,111 |
9,486 |
$1.19M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
2,501 |
2,345 |
$654K |
| A0427 |
Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) |
2,533 |
2,328 |
$550K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
4,971 |
4,623 |
$490K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
3,066 |
3,007 |
$367K |
| A0425 |
Ground mileage, per statute mile |
5,527 |
4,627 |
$323K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
5,330 |
4,674 |
$311K |
| A0429 |
Ambulance service, basic life support, emergency transport (bls-emergency) |
1,715 |
1,555 |
$259K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,336 |
1,296 |
$233K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
3,228 |
3,143 |
$217K |
| 71046 |
Radiologic examination, chest; 2 views |
4,087 |
3,962 |
$157K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
1,503 |
1,194 |
$152K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
4,144 |
1,686 |
$140K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
3,850 |
3,482 |
$125K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
2,021 |
1,823 |
$123K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
3,030 |
1,176 |
$106K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,120 |
1,098 |
$84K |
| A0428 |
Ambulance service, basic life support, non-emergency transport, (bls) |
520 |
481 |
$82K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
636 |
608 |
$59K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
906 |
901 |
$58K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
491 |
481 |
$57K |
| 71045 |
Radiologic examination, chest; single view |
1,337 |
1,313 |
$55K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
3,023 |
940 |
$54K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
1,237 |
1,221 |
$52K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
975 |
942 |
$50K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
2,213 |
869 |
$44K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
1,664 |
718 |
$43K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
632 |
585 |
$40K |
| 80061 |
Lipid panel |
3,449 |
3,427 |
$37K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
5,399 |
5,150 |
$36K |
| 58661 |
|
12 |
12 |
$36K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,260 |
1,178 |
$36K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
2,291 |
2,087 |
$35K |
| 80053 |
Comprehensive metabolic panel |
14,988 |
13,519 |
$33K |
| A0998 |
Ambulance response and treatment, no transport |
202 |
181 |
$31K |
| 84443 |
Thyroid stimulating hormone (TSH) |
4,560 |
4,458 |
$30K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
5,742 |
5,240 |
$27K |
| 41899 |
Unlisted procedure, dentoalveolar structures |
295 |
288 |
$25K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
15,836 |
14,008 |
$24K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
319 |
319 |
$21K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,389 |
1,365 |
$20K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,384 |
1,361 |
$20K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,788 |
1,762 |
$18K |
| 36415 |
Collection of venous blood by venipuncture |
22,181 |
18,873 |
$18K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
779 |
774 |
$16K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
333 |
330 |
$16K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
57 |
57 |
$15K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
916 |
906 |
$12K |
| 82947 |
|
541 |
383 |
$11K |
| 0002A |
|
293 |
292 |
$10K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,120 |
1,100 |
$10K |
| 0001A |
|
282 |
282 |
$9K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
5,054 |
4,635 |
$9K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,814 |
1,791 |
$9K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
147 |
147 |
$8K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
349 |
343 |
$8K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
611 |
608 |
$7K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,196 |
1,905 |
$7K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
3,146 |
2,991 |
$7K |
| 82728 |
|
911 |
901 |
$6K |
| 87480 |
|
640 |
632 |
$6K |
| 87660 |
|
642 |
634 |
$6K |
| 87510 |
|
615 |
607 |
$5K |
| 82607 |
|
722 |
715 |
$5K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
54 |
51 |
$5K |
| 86803 |
|
634 |
631 |
$4K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
182 |
177 |
$4K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
149 |
145 |
$4K |
| 86900 |
|
258 |
248 |
$3K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,295 |
2,967 |
$3K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
914 |
902 |
$3K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
135 |
126 |
$3K |
| 81001 |
|
9,062 |
8,446 |
$3K |
| 85027 |
|
1,046 |
966 |
$3K |
| 87186 |
|
993 |
964 |
$3K |
| 84484 |
|
3,294 |
2,708 |
$3K |
| 84439 |
|
578 |
570 |
$3K |
| 87070 |
|
978 |
938 |
$3K |
| 87481 |
|
106 |
105 |
$2K |
| 73630 |
|
223 |
216 |
$2K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
292 |
273 |
$2K |
| 97162 |
|
57 |
57 |
$2K |
| 87634 |
|
109 |
106 |
$2K |
| 83550 |
|
455 |
450 |
$2K |
| 81025 |
|
4,578 |
4,356 |
$2K |
| 83735 |
|
2,357 |
2,073 |
$2K |
| 83540 |
|
535 |
529 |
$2K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
38 |
32 |
$2K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
138 |
138 |
$2K |
| 87088 |
|
593 |
580 |
$2K |
| 83690 |
|
3,857 |
3,518 |
$1K |
| 97164 |
|
55 |
53 |
$1K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
107 |
105 |
$1K |
| 0003A |
|
35 |
35 |
$1K |
| 85610 |
|
1,572 |
1,438 |
$1K |
| 85379 |
|
1,260 |
1,230 |
$962.56 |
| 83605 |
|
1,863 |
1,668 |
$932.43 |
| 99239 |
Hospital discharge day management, more than 30 minutes |
14 |
14 |
$906.69 |
| U0001 |
Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel |
63 |
60 |
$894.83 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
259 |
235 |
$868.67 |
| 90686 |
|
246 |
245 |
$820.41 |
| 86140 |
|
497 |
454 |
$810.73 |
| 84702 |
|
227 |
190 |
$760.14 |
| 73562 |
|
80 |
76 |
$723.80 |
| 93976 |
|
14 |
14 |
$716.17 |
| 90670 |
|
55 |
55 |
$687.00 |
| 87147 |
|
331 |
327 |
$667.93 |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
14 |
14 |
$656.04 |
| 73610 |
|
66 |
64 |
$626.58 |
| 76830 |
Ultrasound, transvaginal |
12 |
12 |
$596.40 |
| 76801 |
|
12 |
12 |
$596.40 |
| 99238 |
Hospital discharge day management, 30 minutes or less |
15 |
14 |
$564.94 |
| 90791 |
Psychiatric diagnostic evaluation |
12 |
12 |
$561.05 |
| 97163 |
|
14 |
13 |
$540.07 |
| 72100 |
|
28 |
27 |
$455.35 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
24 |
24 |
$455.00 |
| 82570 |
|
158 |
158 |
$437.50 |
| 73130 |
|
57 |
55 |
$436.32 |
| 85651 |
|
286 |
278 |
$406.41 |
| 74018 |
|
41 |
39 |
$386.64 |
| 82043 |
|
96 |
96 |
$298.62 |
| 83880 |
|
231 |
222 |
$288.21 |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
24 |
24 |
$265.61 |
| 96161 |
|
45 |
42 |
$254.00 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
125 |
78 |
$217.59 |
| Q3014 |
Telehealth originating site facility fee |
15 |
13 |
$215.10 |
| 87040 |
|
160 |
116 |
$158.78 |
| 73030 |
|
25 |
25 |
$144.76 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
594 |
541 |
$144.30 |
| 84100 |
|
430 |
388 |
$128.73 |
| 82746 |
|
16 |
16 |
$116.21 |
| 85730 |
|
353 |
340 |
$94.11 |
| 86901 |
|
259 |
249 |
$77.19 |
| 86703 |
|
14 |
14 |
$66.38 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
58 |
57 |
$57.05 |
| 81003 |
|
84 |
82 |
$49.76 |
| 87340 |
|
16 |
15 |
$47.95 |
| 86592 |
|
17 |
16 |
$39.32 |
| 86850 |
|
71 |
70 |
$34.83 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
4,893 |
4,466 |
$15.00 |
| 84703 |
|
152 |
147 |
$5.74 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
386 |
352 |
$0.00 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
922 |
818 |
$0.00 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
844 |
749 |
$0.00 |
| 72125 |
Computed tomography, cervical spine; without contrast material |
12 |
12 |
$0.00 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
77 |
74 |
$0.00 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
204 |
186 |
$0.00 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
194 |
160 |
$0.00 |
| 76376 |
|
1,344 |
1,311 |
$0.00 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
37 |
32 |
$0.00 |
| P9604 |
Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge |
109 |
77 |
$0.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
27 |
26 |
$0.00 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
42 |
40 |
$0.00 |
| 91300 |
|
306 |
283 |
$0.00 |
| 90715 |
|
26 |
26 |
$0.00 |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
12 |
12 |
$0.00 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
57 |
54 |
$0.00 |
| 90633 |
|
12 |
12 |
$0.00 |
| 82948 |
|
17 |
13 |
$0.00 |
| 73110 |
|
13 |
12 |
$0.00 |
| 88302 |
|
24 |
24 |
$0.00 |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
14 |
14 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
2,156 |
2,100 |
$0.00 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
748 |
624 |
$0.00 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
589 |
540 |
$0.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
349 |
328 |
$0.00 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
472 |
428 |
$0.00 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
179 |
168 |
$0.00 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
1,961 |
1,911 |
$0.00 |
| J7050 |
Infusion, normal saline solution, 250 cc |
143 |
117 |
$0.00 |
| J2060 |
Injection, lorazepam, 2 mg |
62 |
50 |
$0.00 |
| G0378 |
Hospital observation service, per hour |
39 |
24 |
$0.00 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
64 |
60 |
$0.00 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
435 |
424 |
$0.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
4,906 |
4,546 |
$0.00 |
| 96376 |
|
294 |
264 |
$0.00 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
84 |
82 |
$0.00 |
| 12001 |
|
12 |
12 |
$0.00 |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
221 |
214 |
$0.00 |
| J0500 |
Injection, dicyclomine hcl, up to 20 mg |
29 |
28 |
$0.00 |
| 94760 |
|
13 |
13 |
$0.00 |
| J1630 |
Injection, haloperidol, up to 5 mg |
14 |
14 |
$0.00 |